Carisma Therapeutics Inc. (CARM) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $1.93 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -24.32%. A quarter ago, it was expected that this company would post a loss of $0.56 per share when it actually produced a loss of $0.52, delivering a surprise of 7.14%.Over the last four quarters, the company ha ...